Jifeng Hou
National Medical Products Administration(CN)National Institutes for Food and Drug Control(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Glycosylation and Glycoproteins Research, Virus-based gene therapy research, Long-Term Effects of COVID-19
Most-Cited Works
- → Effectiveness of convalescent plasma therapy in severe COVID-19 patients(2020)2,023 cited
- → The feasibility of convalescent plasma therapy in severe COVID- 19 patients: a pilot study(2020)129 cited
- → Glycan analysis of glycoprotein pharmaceuticals: Evaluation of analytical approaches to Z number determination in pharmaceutical erythropoietin products(2011)14 cited
- → The first Chinese national standards for SARS-CoV-2 neutralizing antibody(2021)12 cited
- → Potent Anti‐SARS‐CoV‐2 Efficacy of COVID‐19 Hyperimmune Globulin from Vaccine‐Immunized Plasma(2022)11 cited
- → Acute pulmonary embolism caused by highly aggregated intravenous immunoglobulin(2015)7 cited
- → Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International Standard(2023)6 cited
- → In vivo study of novelly formulated porcine-derived fibrinogen as an efficient sealant(2015)5 cited
- ヒトフィブリノーゲンH PLCによるにおけるしょ糖の定量分析【Powered by NICT】(2013)
- Comparative proteomic analysis of serums from lung cancer patients with epithelial growth factor receptor extron 19-mutation(2010)